Table 2.
Single regression analysis
| HR | 95% CI | p value | |
|---|---|---|---|
| Age, years | 1.059 | 1.042–1.076 | <0.001 |
| Female, % | 0.548 | 0.373–0.805 | 0.002 |
| Hemodialysis, % | 0.269 | 0.099–0.726 | 0.010 |
| BMI | 0.917 | 0.877–0.958 | <0.001 |
| Diabetes mellitus, % | 1.150 | 0.840–1.575 | 0.384 |
| CVD, % | 2.315 | 1.674–3.201 | <0.001 |
| Atrial fibrillation, % | 2.092 | 1.228–3.563 | 0.007 |
| eGFR, mL/min/1.73 m2 | 1.131 | 1.076–1.189 | <0.001 |
| Creatinine, mg/dL | 0.850 | 0.792–0.912 | <0.001 |
| BUN, mg/dL | 1.003 | 1.076–1.189 | 0.242 |
| Hemoglobin, g/dL | 0.852 | 0.763–0.952 | 0.005 |
| Albumin, g/dL | 0.564 | 0.434–0.732 | <0.001 |
| AST, IU/L | 1.026 | 1.012–1.039 | <0.001 |
| ALT, IU/L | 1.010 | 0.996–1.024 | 0.164 |
| ALP/100, IU/L | 1.124 | 1.072–1.179 | <0.001 |
| Adjusted Ca, mg/dL | 1.318 | 1.119–1.554 | <0.001 |
| Phosphorus, mg/dL | 0.949 | 0.863–1.042 | 0.272 |
| LDL cholesterol, mg/dL | 0.998 | 0.993–1.004 | 0.545 |
| HDL cholesterol, mg/dL | 0.988 | 0.976–0.999 | 0.036 |
| HbA1c, % | 0.989 | 0.805–1.213 | 0.912 |
| BNP, pg/mL | 1.011 | 1.002–1.020 | 0.022 |
| PTH, pg/mL | 0.999 | 0.999–1.000 | 0.109 |
| CRP, mg/dL | 1.061 | 1.021–1.102 | 0.002 |
| Use of CCBs, % | 0.481 | 0.338–0.685 | <0.001 |
Other than that above, uric acid level, sodium level, potassium level, triglyceride level, use of angiotensin receptor blockers or angiotensin-converting enzyme inhibitor, statins and vitamin D receptor agonists are not risk factors for all-cause mortality. HR, hazard ratio; CI, confidence interval; CVD, cardiovascular disease; eGFR, estimated glomerular filtration rate; BUN, blood urea nitrogen; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; LDL, low-density lipoprotein; HDL, high-density lipoprotein; BNP, brain natriuretic peptide; PTH, parathyroid hormone; CRP, C-reactive protein; CCBs, calcium channel blockers.